Cite
Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.
MLA
Ye, Lin, et al. “Induced Pluripotent Stem Cells Offer New Approach to Therapy in Thalassemia and Sickle Cell Anemia and Option in Prenatal Diagnosis in Genetic Diseases.” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 24, June 2009, pp. 9826–30. EBSCOhost, https://doi.org/10.1073/pnas.0904689106.
APA
Ye, L., Chang, J. C., Lin, C., Sun, X., Yu, J., & Kan, Y. W. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proceedings of the National Academy of Sciences of the United States of America, 106(24), 9826–9830. https://doi.org/10.1073/pnas.0904689106
Chicago
Ye, Lin, Judy C Chang, Chin Lin, Xiaofang Sun, Jingwei Yu, and Yuet Wai Kan. 2009. “Induced Pluripotent Stem Cells Offer New Approach to Therapy in Thalassemia and Sickle Cell Anemia and Option in Prenatal Diagnosis in Genetic Diseases.” Proceedings of the National Academy of Sciences of the United States of America 106 (24): 9826–30. doi:10.1073/pnas.0904689106.